Photo via Washington Examiner

Trump official credited for drug-pricing negotiations advances to be RFK Jr.’s No. 2 at HHS

Read the original at Washington Examiner ↗
Cite

Etzel, G. M. (2026, September 24). Trump official credited for drug-pricing negotiations advances to be RFK Jr.’s No. 2 at HHS. Washington Examiner. https://www.washingtonexaminer.com/policy/healthcare/4740156/trump-official-credited-for-drug-pricing-negotiations-advances-to-be-rfk-jr-s-no-2-at-hhs/

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Washington Examiner · collected 2026-09-24 · by Gabrielle M. Etzel

Quick Summary

Chris Klomp, nominated by President Trump for Deputy Health and Human Services secretary under Robert F. Kennedy Jr., was approved by the Senate Finance Committee in a 15-12 vote on Thursday. Klomp, who has been praised by Trump for his role in negotiating drug price deals with pharmaceutical companies to lower prescription costs, faces criticism from Democrats concerned about transparency and industry influence. The negotiations aim to align U.S. drug prices with those of developing nations but have drawn scrutiny over undisclosed incentives provided to pharmaceutical firms.
Written by AI on 2026-09-24, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

Chris Klomp, who served as President Donald Trump’s negotiator for lowering prescription drug prices through the “most-favored nation” (MFN) deals with pharmaceutical companies, has advanced to be the second-in-command at HHS, after being approved by the Senate Finance Committee on a vote of 15-12. Despite concerns from Democrats, Klomp was nominated in February and quickly rose through the ranks at HHS since Trump’s second term began in 2025. His role involved negotiating with 26 pharmaceutical firms to match U.S. prescription drug prices with those in developing countries. Notably, Democratic Senator Sheldon Whitehouse of Rhode Island joined Republicans to support Klomp's nomination, citing ongoing issues with Medicare reimbursement policies affecting his state.

Written for “HHS Deputy Official Change” on 2026-11-21, grounded in this article and the 1 other(s) covering the same event.

How they differ

2 outlets covered “HHS Deputy Official Change”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Washington ExaminerThis outlet24 Sep

Chris Klomp, nominated by President Trump for Deputy Health and Human Services secretary under Robert F. Kennedy Jr., was approved by the Senate Finance Committee in a 15-12 vote on Thursday. Klomp, who has been praised by Trump for his role in negotiating drug price deals with pharmaceutical companies to lower prescription costs, faces criticism from Democrats concerned about transparency and industry influence…

Trump official credited for drug-pricing negotiations advances to be RFK Jr.’s No. 2 at HHS (this article)
Semafor25 Sep

Chris Klomp’s nomination to become the deputy secretary at the Department of Health and Human Services (HHS) has moved forward with Senate support from 14 Republicans and one Democrat, Sheldon Whitehouse of Rhode Island. Whitehouse cited ongoing issues related to Medicare reimbursement in his state as a reason for supporting Klomp’s confirmation. He believes Klomp can assist in resolving longstanding challenges…

Klomp wins over Democrat in bid to be No. 2 HHS official →

Compared with similar articles

This article reads leans left and hedges 9% of its claims. Each row says how that neighbour differs.
Semafor
Leans right further right than this Hedges 0 of 6 claims Outlet record 64/100
NBC News
Leans strongly right further right than this Hedges 3 of 26 claims Outlet record 74/100
“The articles describe different confirmation hearings for two separate officials, Dr. Heidi Overton and Chris Klomp.”

Story

HHS Deputy Official Change
Politics · 2 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
23
sentences that state something as happening or true
Uncertain
9%
2 of 23 hedged ("reportedly", "may", "according to")
Leaning
Leans left
of the writing, not the subject · beta estimate
Publisher signals
67/100
Washington Examiner's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-24 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Washington Examiner · 5274 article(s) · 11 correction(s) detected
Running correction rate · 11 correction(s)

Who wrote this

Gabrielle M. Etzel
52 article(s) here · 1 carrying a prediction
Sen. Bernie Sanders (I-VT) said he believes his single-payer healthcare Medicare for All legislation will receive a vote on the Senate floor regardless of who becomes the next Senate majority leader.
Income level has virtually no effect on whether people serve as a primary caregiver, a finding that could give support to calls from Democrats to expand long-term care benefits for seniors and people with disabilities.
The future of “Medicare for all” over the next two years will depend heavily on whom Senate Democrats choose as their next majority leader.
Means, who quit his post as Trump administration health policy adviser in late October, said on CBS News’s Face the Nation Sunday that he would like to see the Trump administration work with Democrats on key food reform legislation where there is much common ground.
The Pan-American Health Organization, part of the public health arm of the United Nations, will meet Tuesday through Thursday to determine whether measles has become endemic, or continuously circulating, in both Mexico and the U.S.
The newly elected Democratic majorities in the House and Senate will face significant pressure from voters to deliver lower healthcare costs next year in the lead-up to the 2028 presidential cycle.
2026-11-06 · assertive framing · High pressure on Democrats to lower healthcare costs
Anti-abortion advocates worry that President Donald Trump may be pushed by the new Democratic majorities in the House and Senate to back down on anti-abortion priorities.
Unlike the abortion-related ballot measures in other states, Prop 1 is only legislation rather than a constitutional amendment, meaning that an act of the state legislature could repeal it.
Question 6, which will establish a “fundamental right to abortion,” was ahead by a vote of 62.3% to 37.7% with 86% of the vote counted.
Amendment 3, which would have repealed a 2024 constitutional amendment legalizing abortion, failed by a vote of 55.2% to 44.8% when the Associated Press called the result at 11:18 p.m., with about 94% of the ballots counted. Recommended Stories Eleven states, including Missouri, have passed abortion rights amendments by ballot initiative since the Dobbs v. Jackson Women’s Health Organization decision in June 2022.
Also by Gabrielle M. Etzel
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 52 articles by Gabrielle M. Etzel →

Topics

Democrats HHS Health and Human Services MFN Senate Finance

Subjects

Klomp PERSON · 15× Trump PERSON · 5× Democrats NORP · 4× HHS ORG · 4× Kennedy PERSON · 3× MFN ORG · 2× Senate Finance ORG · 2× Chris Klomp PERSON · 1× Donald Trump PERSON · 1× Health and Human Services ORG · 1×

Narrative

Senate Finance Chairman Mike Crapo (R-ID) said in his opening statement that Klomp made the case during his confirmation hearing that he is best suited for the second-in-command role at HHS with the job of “aligning people, policy, technology, and resources around clear objectives and measurable results.”
framing: assertive · carried by 1 article(s) · first seen 2026-09-24
Warren said she and others in Congress would like to see “what was given away in these contracts” as incentives for drug companies to voluntarily lower their prices, such as tariff exemptions or fast-tracked approvals from the Food and Drug Administration.

Claims (23 extracted, 2 hedged)

Chris Klomp, President Donald Trump’s nominee for Deputy Health and Human Services secretary, was approved by the Senate Finance Committee despite concerns from Democrats about his role helping the administration reach deals with pharmaceutical companies to lower the price of prescription drugs. asserted
administration → approve → drugs
Klomp, who has been serving as HHS Secretary Robert F. Kennedy Jr.’s top adviser since February, was approved on Thursday in a vote of 15-12, advancing to the full Senate for a final confirmation vote. asserted
who → serve → vote
Sen. Sheldon Whitehouse (D-RI) joined all Republicans on the committee to move Klomp’s nomination forward. asserted
Whitehouse → join → nomination
Klomp has risen quickly through the ranks at HHS since the beginning of Trump’s second term. asserted
Klomp → rise → term
He initially joined the administration in 2025 as the director of Medicare, serving under Dr. Mehmet Oz at the Centers for Medicare and Medicaid Services. asserted
He → join → Services
In that role, Klomp distinguished himself as a chief negotiator with pharmaceutical companies for the president’s “most-favored nation” drug price deals, and was subsequently appointed as Kennedy’s chief counselor. asserted
Klomp → distinguish → counselor
The MFN drug-pricing deals, reached with 26 pharmaceutical companies to lower U.S. prescription prices to match those of developing nations, have been the centerpiece of the Trump administration’s affordability agenda ahead of the 2026 midterm elections. asserted
deals → reach → elections
Senate Finance Chairman Mike Crapo (R-ID) said in his opening statement that Klomp made the case during his confirmation hearing that he is best suited for the second-in-command role at HHS with the job of “aligning people, policy, technology, and resources around clear objectives and measurable results.” asserted
he → say → objectives
“I appreciated his commitment to ensuring that HHS effectively carries out its mission and empowers its talented workforce to address the pressing health challenges facing our country,” Crapo said. asserted
Crapo → appreciate → country
Klomp has received praise from Trump for spearheading the MFN negotiations, but his involvement in the pharmaceutical deals has led to Democrats raising criticisms about his proximity to the industry. asserted
Democrats → receive → industry
Before joining the Trump administration, Klomp founded and ran an electronic medical records company, which he eventually sold in 2020. asserted
he → join → 2020
He subsequently advised various upstart healthcare companies, including the fertility benefits company Maven, which provides in vitro fertilization and surrogacy care. asserted
which → advise → fertilization
During Klomp’s Senate Finance hearing, Sen. Elizabeth Warren (D-MA) in particular lambasted Klomp about the secrecy of the administration’s deals, demanding that he “show [her] the receipts.” asserted
he → lambast → receipts
Warren said she and others in Congress would like to see “what was given away in these contracts” as incentives for drug companies to voluntarily lower their prices, such as tariff exemptions or fast-tracked approvals from the Food and Drug Administration. asserted
companies → say → Administration
Sen. Ron Wyden (D-OR), the ranking Democrat on the committee, criticized Klomp as being unwilling to share details about the pharmaceutical deals with members of the committee. “All we have received are excuses and misrepresentation,” Wyden said. asserted
Wyden → criticize → committee
“I laid out in writing each request I made to provide the facts to the American people. asserted
I → lay → people
Until these details are made public, I will keep fighting to impede Mr. Klomp’s nomination.” asserted
I → make → nomination
Klomp was also pressed by Democrats about his loyalty to both the president and Kennedy and whether he is free to disagree with them. asserted
he → press → them
In particular, Democrats wanted to know whether Klomp agreed with Kennedy and Trump that childhood vaccines may be linked to autism. uncertain
vaccines → want → autism
“I have plenty of disagreements with the secretary, and I express those plainly and candidly,” Klomp said. asserted
Klomp → have → those
“I have a reputation for speaking extremely plainly, and in that process, I have earned the trust of the secretary and the president. asserted
I → have → secretary
They always know where I stand. asserted
I → know → ?
When asked directly by Sen. Raphael Warnock (D-GA) about whether the measles, mumps, and rubella vaccine causes autism, Klomp said he has “not seen a preponderance of evidence that suggests it causes autism.” uncertain
it → ask → autism
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support